Related Experiment Videos
Thromboxane A2 augments adrenergic neurotransmission.
1Department of Pharmacology, University of Minnesota-Duluth, School of Medicine 55812.
Eicosanoids
|January 1, 1990
Summary
Thromboxane A2 (TXA2) generated by platelet microsomes enhances neurotransmission in rabbit mesenteric arteries. TXA2 potentiates both pre- and post-junctional adrenergic signaling, influencing contractile force and norepinephrine release.
Area of Science:
- Vascular Pharmacology
- Neurotransmission Studies
- Biochemistry
Background:
- Thromboxanes are potent mediators of vascular function.
- Their role in modulating neurotransmission in mesenteric arteries is not fully understood.
Purpose of the Study:
- To investigate the effects of thromboxane A2 (TXA2) on neurotransmission in isolated rabbit superior mesenteric arteries.
- To determine if TXA2 influences contractile force, neurogenic contractions, norepinephrine-induced contractions, and norepinephrine release.
Main Methods:
- Platelet microsomes were used to generate TXA2 in rabbit isolated superior mesenteric arteries.
- Contractile force, neurogenic contractions, and norepinephrine-induced contractions were measured.
- Electrically stimulated norepinephrine release was assessed.
- Thromboxane B2 concentrations were quantified and correlated with observed responses.
Main Results:
- Microsomal TXA2 generation significantly increased basal contractile force.
- Neurogenic contractions were enhanced to 303% of control.
- Electrically stimulated norepinephrine release increased to 270% of control.
- Exogenous TXA2 augmented adrenergic neurotransmission and contractions at concentrations >1 microM.
Conclusions:
- TXA2 plays a potentiative neuromodulatory role in mesenteric arteries.
- This modulation occurs through both pre- and post-junctional mechanisms.
- TXA2 influences vascular tone and adrenergic signaling pathways.